Citation 88481

CICHEWICZ,RH: NAIR,MG:. (2002). ISOLATION AND CHARACTERIZATION OF STELLADEROL, A NEW ANTIOXIDANT NAPHTHALENE GLYCOSIDE, AND OTHER ANTIOXIDANT GLYCOSIDES FROM EDIBLE DAYLILY (HEMEROCALLIS) FLOWERS.. 50(1)

Citation Details

Title	ISOLATION AND CHARACTERIZATION OF STELLADEROL, A NEW ANTIOXIDANT NAPHTHALENE GLYCOSIDE, AND OTHER ANTIOXIDANT GLYCOSIDES FROM EDIBLE DAYLILY (HEMEROCALLIS) FLOWERS.
Authors	CICHEWICZ,RH: NAIR,MG:
Year	2002
Volume	50
Issue	1

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Hemerocallis species (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	JUGLANIN	None
3	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLANIN	INACTIVE
4	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLANIN	INACTIVE
5	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLANIN	EQUIVOCAL
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-BETA-D-XYLOPYRANOSIDE	None
7	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-BETA-D-XYLOPYRANOSIDE	INACTIVE
8	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-BETA-D-XYLOPYRANOSIDE	INACTIVE
9	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-BETA-D-XYLOPYRANOSIDE	ACTIVE
10	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ASTRAGALIN	None
11	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	INACTIVE
12	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	INACTIVE
13	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	EQUIVOCAL
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCITRIN,ISO:	None
15	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	INACTIVE
16	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	INACTIVE
17	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	ACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	None
19	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
20	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
21	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANSOYL(1-6)-BETA-D-GLUCOPYRANOSIDE	None
23	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANSOYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
24	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANSOYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
25	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANSOYL(1-6)-BETA-D-GLUCOPYRANOSIDE	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GALACTOPYRANOSIDE	None
27	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GALACTOPYRANOSIDE	INACTIVE
28	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GALACTOPYRANOSIDE	INACTIVE
29	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-BETA-D-GALACTOPYRANOSIDE	WEAK ACTIVITY
30	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	None
31	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	INACTIVE
32	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	INACTIVE
33	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAMNETIN,ISO: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	None
35	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	INACTIVE
36	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	INACTIVE
37	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO: 3-O-ALPHA-L-RHAMNOPYRANOSYL(1-6)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSIDE	EQUIVOCAL
38	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHENETHYL-BETA-D-GLUCOPYRANOSIDE	None
39	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENETHYL-BETA-D-GLUCOPYRANOSIDE	INACTIVE
40	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENETHYL-BETA-D-GLUCOPYRANOSIDE	INACTIVE
41	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENETHYL-BETA-D-GLUCOPYRANOSIDE	EQUIVOCAL
42	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ORCINOL-BETA-D-GLUCOPYRANOSIDE	None
43	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ORCINOL-BETA-D-GLUCOPYRANOSIDE	INACTIVE
44	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ORCINOL-BETA-D-GLUCOPYRANOSIDE	INACTIVE
45	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ORCINOL-BETA-D-GLUCOPYRANOSIDE	EQUIVOCAL
46	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ORCINOL-BETA-D-GLUCOPYRANOSIDEPHLORETIN-2'-O-BETA-D-GLUCOPYRANOSIDE	None
47	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-GLUCOPYRANOSIDE	INACTIVE
48	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-GLUCOPYRANOSIDE	INACTIVE
49	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-GLUCOPYRANOSIDE	EQUIVOCAL
50	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHLORETIN-2'-O-BETA-D-XYLOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	None
51	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-XYLOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
52	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-XYLOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	INACTIVE
53	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHLORETIN-2'-O-BETA-D-XYLOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE	EQUIVOCAL
54	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STELLADEROL	None
55	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STELLADEROL	INACTIVE
56	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STELLADEROL	INACTIVE
57	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	STELLADEROL	STRONG ACTIVITY
58	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LONGITUBANINE A	None
59	CYCLOOXYGENASE 1 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LONGITUBANINE A	INACTIVE
60	CYCLOOXYGENASE 2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LONGITUBANINE A	INACTIVE
61	ANTIOXIDANT ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LONGITUBANINE A	EQUIVOCAL

Citation 88481

Citation Details

Summary

Organisms and Their Experiments (1)

Hemerocallis species (LILIACEAE)

Show SPARQL Queries (1)

Query 1